skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8121

Update on thyroid eye disease and management

Review

(3478) Views  (1350) Full article downloads

Authors: Erick D Bothun, Ryan A Scheurer, Andrew R Harrison, et al

Published Date October 2009 Volume 2009:3 Pages 543 - 551
DOI: http://dx.doi.org/10.2147/OPTH.S5228

Erick D Bothun,1,2 Ryan A Scheurer,1 Andrew R Harrison,1,3 Michael S Lee1,4,5

1Departments of Ophthalmology, 2Pediatrics, 3Otolaryngology, 4Neurosurgery, and 5Neurology, University of Minnesota, Minneapolis, Minnesota, USA

Abstract: Thyroid eye disease is a heterogeneous autoimmune orbital reaction typically manifesting in middle age. The inflammation may parallel or remain isolated from a related inflammatory cascade in the thyroid called Graves’ disease. The orbital manifestations can lead to severe proptosis, dry eyes, strabismus, and optic neuropathy. In this article, we will discuss this unique condition including the ophthalmic findings and management.

Keywords: Graves’ disease, thyroid eye disease, proptosis, orbital decompression, enlarged extraocular muscles






 

Other articles by Dr Andrew Harrison

Profile of Xeomin® (incobotulinumtoxinA) for the treatment of blepharospasm